Ken Griffin
PRNB

Ken Griffin’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Ken Griffin’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-801,539
Closed -$47.9M – 11106
2020
Q2 		$47.9M Sell
801,539
-33,676
-4% -$2.08M 0.02% 830
2020
Q1 		$49.6M Buy
835,215
+690,755
+478% +$40.3M 0.02% 648
2019
Q4 		$7.91M Buy
144,460
+136,564
+1,730% +$5.1M ﹤0.01% 2482
2019
Q3 		$223K Buy
+7,896
New +$290K ﹤0.01% 8016
2018
Q4 		– Sell
-7,206
Closed -$211K – 10086
2018
Q3 		$211K Buy
+7,206
New +$203K ﹤0.01% 8143

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Ken Griffin's PRNB Position: Q3 2020 in Review

Ken Griffin sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 801,539 shares — an estimated $47.9M sold.

Ken Griffin first reported a position in PRNB in Q3 2018 and held it in 5 quarters. The position peaked at $49.6M in Q1 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Ken Griffin reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Ken Griffin sold 801,539 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $47.9M.
  • Ken Griffin first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 5 quarters.
  • Ken Griffin's Principia Biopharma Inc. Common Stock position peaked at $49.6M in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.